Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.

Hartung HP, Gonsette R, K├Ânig N, Kwiecinski H, Guseo A, Morrissey SP, Krapf H, Zwingers T; Mitoxantrone in Multiple Sclerosis Study Group (MIMS).

Lancet. 2002 Dec 21-28;360(9350):2018-25.

PMID:
12504397
2.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
3.

Management of worsening multiple sclerosis with mitoxantrone: a review.

Fox EJ.

Clin Ther. 2006 Apr;28(4):461-74. Review.

PMID:
16750460
4.

Mitoxantrone for multiple sclerosis.

Martinelli Boneschi F, Rovaris M, Capra R, Comi G.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002127. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD002127.

PMID:
16235298
5.

Review of mitoxantrone in the treatment of multiple sclerosis.

Jeffery DR, Herndon R.

Neurology. 2004 Dec 28;63(12 Suppl 6):S19-24. Review.

PMID:
15623665
6.

[Mitoxantrone (Novantron) in therapy of severe multiple sclerosis. A retrospective study of 15 patients].

Cursiefen S, Flachenecker P, Rieckmann P, Toyka KV.

Nervenarzt. 1999 Aug;70(8):723-31. Review. German. Erratum in: Nervenarzt 1999 Dec;70(12):1051.

PMID:
10483572
7.

Mitoxantrone for multiple sclerosis in clinical practice.

Rizvi SA, Zwibel H, Fox EJ.

Neurology. 2004 Dec 28;63(12 Suppl 6):S25-7. Review.

PMID:
15623666
8.

Mitoxantrone in progressive multiple sclerosis: when and how to treat?

Gonsette RE.

J Neurol Sci. 2003 Feb 15;206(2):203-8. Review.

PMID:
12559512
9.

The current role of mitoxantrone in the treatment of multiple sclerosis.

Cocco E, Marrosu MG.

Expert Rev Neurother. 2014 Jun;14(6):607-16. doi: 10.1586/14737175.2014.915742. Epub 2014 May 16. Review.

PMID:
24834466
10.

[Mitoxantrone].

Pericot I, Montalban X.

Neurologia. 2003 Jul-Aug;18(6):318-23. Review. Spanish.

PMID:
12838451
11.

Rationale for the use of mitoxantrone in multiple sclerosis.

Edan G, Morrissey S, Le Page E.

J Neurol Sci. 2004 Aug 15;223(1):35-9. Review.

PMID:
15261558
12.

Mitoxantrone: benefits and risks in multiple sclerosis patients.

Martinelli V, Radaelli M, Straffi L, Rodegher M, Comi G.

Neurol Sci. 2009 Oct;30 Suppl 2:S167-70. doi: 10.1007/s10072-009-0142-7. Review.

PMID:
19882368
13.

Mitoxantrone (Novantrone) in multiple sclerosis: new insights.

Neuhaus O, Kieseier BC, Hartung HP.

Expert Rev Neurother. 2004 Jan;4(1):17-26. Review.

PMID:
15853611
14.

[Mitoxantrone for the treatment of patients with multiple sclerosis].

Komori M, Kondo T, Tanaka M.

Brain Nerve. 2009 May;61(5):575-80. Review. Japanese.

PMID:
19514518
15.

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Goodin DS, Arnason BG, Coyle PK, Frohman EM, Paty DW; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Neurology. 2003 Nov 25;61(10):1332-8. Review.

PMID:
14638950
16.

Therapy-related acute leukaemia with mitoxantrone: four years on, what is the risk and can it be limited?

Ellis R, Brown S, Boggild M.

Mult Scler. 2015 Apr;21(5):642-5. doi: 10.1177/1352458514541508. Epub 2014 Jul 10. Review.

PMID:
25013152
17.

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Neurology. 2010 May 4;74(18):1463-70. doi: 10.1212/WNL.0b013e3181dc1ae0. Review.

18.

Mitoxantrone in the treatment of multiple sclerosis.

Morrissey SP, Le Page E, Edan G.

Int MS J. 2005 Nov;12(3):74-87. Review.

PMID:
16417821
19.

[Mitoxanthrone in the therapy of multiple sclerosis].

Kieseier BC, Gold R, Hartung HP.

Nervenarzt. 2003 Oct;74(10):906-10. Review. German.

PMID:
14551698
20.

Supplemental Content

Support Center